Trial intelligence / Profile preview

Celgosivir in Acute Dengue Fever

NCT01619969Phase 2Completed

Sponsor
Singapore General Hospital
Start
Jul 2012
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of celgosivir in dengue fever, sponsored by Singapore General Hospital. Started Jul 2012; status: completed.

02

Drugs

celgosivir
03

Conditions

dengue fever

Beyond the preview

Go deeper on NCT01619969.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01619969.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call